These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 8391821)

  • 1. Synthesis and opioid receptor affinity of bivalent ligands derived from 3,8-diazabicyclo(3.2.1)octanes.
    Barlocco D; Fadda P; Fratta W
    Farmaco; 1993 Mar; 48(3):387-96. PubMed ID: 8391821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, modelling, and mu-opioid receptor affinity of N-3(9)-arylpropenyl-N-9(3)-propionyl-3,9-diazabicycl.
    Pinna GA; Murineddu G; Curzu MM; Villa S; Vianello P; Borea PA; Gessi S; Toma L; Colombo D; Cignarella G
    Farmaco; 2000 Aug; 55(8):553-62. PubMed ID: 11132733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of 3,8-diazabicyclo (3.2.1) octanes with mu and delta opioid receptors.
    Cignarella G; Barlocco D; Tranquillini ME; Volterra A; Brunello N; Racagni G
    Pharmacol Res Commun; 1988 May; 20(5):383-94. PubMed ID: 2843931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of 3,6-diazabicyclo[3.1.1]heptanes as novel ligands for the opioid receptors.
    Loriga G; Manca I; Murineddu G; Chelucci G; Villa S; Gessi S; Toma L; Cignarella G; Pinna GA
    Bioorg Med Chem; 2006 Feb; 14(3):676-91. PubMed ID: 16243530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and mu-opioid receptor affinity of a new series of nitro substituted 3,8-diazabicyclo[3.2.1]octane derivatives.
    Barlocco D; Cignarella G; Vianello P; Villa S; Pinna GA; Fadda P; Fratta W
    Farmaco; 1998; 53(8-9):557-62. PubMed ID: 10081818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and analgesic activity of some 5-(4-hydroxyphenyl)-2-azabicyclo[3.2.1]octanes.
    Ong HH; Anderson VB; Wilker JC; Spaulding TC; Meyerson LR
    J Med Chem; 1980 Jul; 23(7):726-9. PubMed ID: 6249930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benzocondensed derivatives as rigid analogues of the mu-opioid agonist 3(8)-cinnamyl-8(3)-propionyl-3,8-diazabicyclo[3.2.1]octanes: synthesis, modeling, and affinity.
    Cignarella G; Barlocco D; Vianello P; Villa S; Pinna GA; Fadda P; Fratta W; Toma L; Gessi S
    Farmaco; 1998; 53(10-11):667-74. PubMed ID: 10205853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metopon and two unique derivatives: affinity and selectivity for the multiple opioid receptors.
    McLaughlin JP; Nowak D; Sebastian A; Schultz AG; Archer S; Bidlack JM
    Eur J Pharmacol; 1995 Dec; 294(1):201-6. PubMed ID: 8788432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of a 6-cyano substituent in 14-oxygenated N-methylmorphinans on opioid receptor binding and antinociceptive potency.
    Spetea M; Greiner E; Aceto MD; Harris LS; Coop A; Schmidhammer H
    J Med Chem; 2005 Jul; 48(15):5052-5. PubMed ID: 16033285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and opioid receptor affinity of a series of 2, 4-diaryl-substituted 3,7-diazabicylononanones.
    Siener T; Cambareri A; Kuhl U; Englberger W; Haurand M; Kögel B; Holzgrabe U
    J Med Chem; 2000 Oct; 43(20):3746-51. PubMed ID: 11020289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design and synthesis of novel opioid ligands with an azabicyclo[2.2.2]octane skeleton and their pharmacologies.
    Watanabe Y; Kitazawa S; Fujii H; Nemoto T; Hirayama S; Nagase H
    Bioorg Med Chem Lett; 2012 Apr; 22(8):2689-92. PubMed ID: 22445285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of novel diazatricyclodecanes (DTDs). Effects of structural variation at the C3' allyl end and at the phenyl ring of the cinnamyl chain on mu-receptor affinity and opioid antinociception.
    Pinna GA; Cignarella G; Ruiu S; Loriga G; Murineddu G; Villa S; Grella GE; Cossu G; Fratta W
    Bioorg Med Chem; 2003 Sep; 11(18):4015-26. PubMed ID: 12927864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of [Dmt1]DALDA and DAMGO in binding and G protein activation at mu, delta, and kappa opioid receptors.
    Zhao GM; Qian X; Schiller PW; Szeto HH
    J Pharmacol Exp Ther; 2003 Dec; 307(3):947-54. PubMed ID: 14534366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, molecular modeling, and opioid receptor affinity of 9, 10-diazatricyclo[4.2.1.1(2,5)]decanes and 2,7-diazatricyclo[4.4.0. 0(3,8)]decanes structurally related to 3,8-diazabicyclo[3.2. 1]octanes.
    Vianello P; Albinati A; Pinna GA; Lavecchia A; Marinelli L; Borea PA; Gessi S; Fadda P; Tronci S; Cignarella G
    J Med Chem; 2000 Jun; 43(11):2115-23. PubMed ID: 10841790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Characterization of 9 slowly dissociated opioid ligands azabicyclononances compounds to mu, delta, and kappa receptors].
    Fan LQ; Jin WQ; Chi ZQ
    Zhongguo Yao Li Xue Bao; 1991 May; 12(3):245-9. PubMed ID: 1664168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and in vitro and in vivo activity of (-)-(1R,5R,9R)- and (+)-(1S,5S,9S)-N-alkenyl-, -N-alkynyl-, and -N-cyanoalkyl-5, 9-dimethyl-2'-hydroxy-6,7-benzomorphan homologues.
    May EL; Jacobson AE; Mattson MV; Traynor JR; Woods JH; Harris LS; Bowman ER; Aceto MD
    J Med Chem; 2000 Dec; 43(26):5030-6. PubMed ID: 11150174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A potent and long-lasting ligand, azabicyclononane (P-7521).
    Chi ZQ; Jin WQ
    Prog Clin Biol Res; 1990; 328():1-4. PubMed ID: 2154758
    [No Abstract]   [Full Text] [Related]  

  • 18. Morphine can produce analgesia via spinal kappa opioid receptors in the absence of mu opioid receptors.
    Yamada H; Shimoyama N; Sora I; Uhl GR; Fukuda Y; Moriya H; Shimoyama M
    Brain Res; 2006 Apr; 1083(1):61-9. PubMed ID: 16530171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the complex morphinan derivative BU72 as a high efficacy, long-lasting mu-opioid receptor agonist.
    Neilan CL; Husbands SM; Breeden S; Ko MC; Aceto MD; Lewis JW; Woods JH; Traynor JR
    Eur J Pharmacol; 2004 Sep; 499(1-2):107-16. PubMed ID: 15363957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kappa-receptor selective binding of opioid ligands with a heterocyclic bicyclo[3.3.1]nonan-9-one structure.
    Benyhe S; Márki A; Nachtsheim C; Holzgrabe U; Borsodi A
    Acta Biol Hung; 2003; 54(2):147-55. PubMed ID: 14535620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.